{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T01:17:09Z","timestamp":1790299029287,"version":"4.1.0"},"reference-count":75,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,21]],"date-time":"2023-01-21T00:00:00Z","timestamp":1674259200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["71804093"],"award-info":[{"award-number":["71804093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Comprehensive Psychiatry"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/j.comppsych.2023.152370","type":"journal-article","created":{"date-parts":[[2023,1,23]],"date-time":"2023-01-23T10:56:40Z","timestamp":1674471400000},"page":"152370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"special_numbering":"C","title":["Association between autoimmune diseases of the nervous system and schizophrenia: A systematic review and meta-analysis of cohort studies"],"prefix":"10.1016","volume":"122","author":[{"given":"Yiting","family":"Cao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yujiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoshuai","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoyong","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.comppsych.2023.152370_bb0005","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/s41582-019-0174-4","article-title":"Immunoneuropsychiatry - novel perspectives on brain disorders","volume":"15","author":"Pape","year":"2019","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/j.comppsych.2023.152370_bb0010","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neuropharm.2017.04.046","article-title":"Autoantibody-mediated diseases of the CNS: structure, dysfunction and therapy","volume":"132","author":"Varley","year":"2018","journal-title":"Neuropharmacology."},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0015","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.mcna.2018.10.004","article-title":"Multiple sclerosis and autoimmune neurology of the central nervous system","volume":"103","author":"Galetta","year":"2019","journal-title":"Med Clin North Am"},{"issue":"Pt 1","key":"10.1016\/j.comppsych.2023.152370_bb0020","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1258\/acb.2011.011140","article-title":"Immunological markers in neurological disorders","volume":"49","author":"Karim","year":"2012","journal-title":"Ann Clin Biochem"},{"issue":"4","key":"10.1016\/j.comppsych.2023.152370_bb0025","doi-asserted-by":"crossref","first-page":"121","DOI":"10.4038\/cmj.v60i4.8218","article-title":"Friendly fire on neurons: antibody-mediated diseases of the nervous system","volume":"60","author":"Chang","year":"2015","journal-title":"Ceylon Med J"},{"key":"10.1016\/j.comppsych.2023.152370_bb0030","first-page":"451","article-title":"Depressive syndromes in autoimmune disorders of the nervous system: prevalence, etiology, and influence","volume":"9","author":"Liu","year":"2018","journal-title":"Front Psychol"},{"issue":"6","key":"10.1016\/j.comppsych.2023.152370_bb0035","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1093\/schbul\/sby058","article-title":"Global epidemiology and burden of schizophrenia: findings from the global burden of disease study 2016","volume":"44","author":"Charlson","year":"2018","journal-title":"Schizophr Bull"},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0040","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/S2215-0366(21)00395-3","article-title":"Global, regional, and national burden of 12 mental disorders in 204 countries and territories, 1990-2019: a systematic analysis for the global burden of disease study 2019","volume":"9","author":"Alize","year":"2022","journal-title":"Lancet Psychiatry"},{"issue":"10039","key":"10.1016\/j.comppsych.2023.152370_bb0045","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0140-6736(15)01121-6","volume":"388","author":"Owen","year":"2016","journal-title":"Schizophrenia Lancet"},{"issue":"4","key":"10.1016\/j.comppsych.2023.152370_bb0050","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.biopsych.2013.09.023","article-title":"The epidemiologic evidence linking autoimmune diseases and psychosis","volume":"75","author":"Benros","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2023.152370_bb0055","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/B978-0-444-63432-0.00015-3","article-title":"Autoimmunity in neuropsychiatric disorders","volume":"133","author":"Coutinho","year":"2016","journal-title":"Handb Clin Neurol"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0060","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.biopsych.2018.06.016","article-title":"Associations between non-neurological autoimmune disorders and psychosis: a Meta-analysis","volume":"85","author":"Cullen","year":"2019","journal-title":"Biol Psychiatry"},{"issue":"3","key":"10.1016\/j.comppsych.2023.152370_bb0065","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/imm.12795","article-title":"Psychosis: an autoimmune disease","volume":"152","author":"Al-Diwani","year":"2017","journal-title":"Immunology."},{"key":"10.1016\/j.comppsych.2023.152370_bb0070","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/7854_2019_93","article-title":"Role of infection, autoimmunity, atopic disorders, and the immune system in schizophrenia: evidence from epidemiological and genetic studies","volume":"44","author":"Benros","year":"2020","journal-title":"Curr Top Behav Neurosci"},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0075","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1176\/appi.ajp.2013.13010086","article-title":"A nationwide study on the risk of autoimmune diseases in individuals with a personal or a family history of schizophrenia and related psychosis","volume":"171","author":"Benros","year":"2014","journal-title":"Am J Psychiatry"},{"issue":"14","key":"10.1016\/j.comppsych.2023.152370_bb0080","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1177\/1352458514540970","article-title":"Multiple sclerosis and psychiatric disorders: comorbidity and sibling risk in a nationwide Swedish cohort","volume":"20","author":"Johansson","year":"2014","journal-title":"Mult Scler"},{"issue":"3","key":"10.1016\/j.comppsych.2023.152370_bb0085","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1176\/appi.ajp.163.3.521","article-title":"Association of schizophrenia and autoimmune diseases: linkage of Danish national registers","volume":"163","author":"Eaton","year":"2006","journal-title":"Am J Psychiatry"},{"issue":"12","key":"10.1016\/j.comppsych.2023.152370_bb0090","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1176\/appi.ajp.2011.11030516","article-title":"Autoimmune diseases and severe infections as risk factors for schizophrenia: a 30-year population-based register study","volume":"168","author":"Benros","year":"2011","journal-title":"Am J Psychiatry"},{"issue":"15","key":"10.1016\/j.comppsych.2023.152370_bb0095","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis of observational studies in epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA."},{"issue":"7","key":"10.1016\/j.comppsych.2023.152370_bb0100","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000097","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"6","author":"Moher","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/j.comppsych.2023.152370_bb0105","author":"GA Wells"},{"key":"10.1016\/j.comppsych.2023.152370_bb0110","article-title":"Association between infections and risk of ankylosing spondylitis: a systematic review and Meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Immunol"},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0115","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/j.1756-185X.2012.01712.x","article-title":"Conducting a meta-analysis: basics and good practices","volume":"15","author":"Cheung","year":"2012","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.comppsych.2023.152370_bb0120","series-title":"Cochrane Handbook for Systematic Reviews of Interventions Version","first-page":"3","volume":"6","author":"Julian Higgins","year":"2022"},{"key":"10.1016\/j.comppsych.2023.152370_bb0125","first-page":"662","article-title":"Risk of schizophrenia and bipolar disorder in patients with multiple sclerosis: record-linkage studies","volume":"11","author":"Meier","year":"2020","journal-title":"Front Psychol"},{"issue":"22","key":"10.1016\/j.comppsych.2023.152370_bb0130","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1212\/WNL.0000000000002174","article-title":"Differences in the burden of psychiatric comorbidity in MS vs the general population","volume":"85","author":"Marrie","year":"2015","journal-title":"Neurology."},{"issue":"14","key":"10.1016\/j.comppsych.2023.152370_bb0135","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1212\/WNL.0000000000002481","article-title":"Sex differences in comorbidity at diagnosis of multiple sclerosis: a population-based study","volume":"86","author":"Marrie","year":"2016","journal-title":"Neurology."},{"key":"10.1016\/j.comppsych.2023.152370_bb0140","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.schres.2018.06.033","article-title":"Autoimmune diseases are associated with an increased risk of schizophrenia: a nationwide population-based cohort study","volume":"202","author":"Wang","year":"2018","journal-title":"Schizophr Res"},{"key":"10.1016\/j.comppsych.2023.152370_bb0145","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/NDT.S268360","article-title":"Risk of psychiatric disorders in multiple sclerosis: a Nationwide cohort study in an Asian population","volume":"17","author":"Huang","year":"2021","journal-title":"Neuropsychiatr Dis Treat"},{"issue":"7510","key":"10.1016\/j.comppsych.2023.152370_bb0150","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1038\/nature13595","article-title":"Biological insights from 108 schizophrenia-associated genetic loci","volume":"511","author":"Stephan Ripke","year":"2014","journal-title":"Nature."},{"issue":"4","key":"10.1016\/j.comppsych.2023.152370_bb0155","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1007\/s11481-013-9467-3","article-title":"The immune pathogenesis of multiple sclerosis","volume":"8","author":"Weissert","year":"2013","journal-title":"J NeuroImmune Pharmacol"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0160","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1352458517739989","article-title":"Multiple sclerosis and HLA genotypes: a possible influence on brain atrophy","volume":"25","author":"Lorefice","year":"2019","journal-title":"Mult Scler"},{"issue":"11","key":"10.1016\/j.comppsych.2023.152370_bb0165","doi-asserted-by":"crossref","DOI":"10.1016\/j.autrev.2020.102665","article-title":"Genetic polymorphisms in Guillain-Barr\u00e9 syndrome: a field synopsis and systematic meta-analysis","volume":"19","author":"Zhao","year":"2020","journal-title":"Autoimmun Rev"},{"issue":"23","key":"10.1016\/j.comppsych.2023.152370_bb0170","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1212\/WNL.0b013e3181e24124","article-title":"Multiple sclerosis, vitamin D, and HLA-DRB1*15","volume":"74","author":"Handunnetthi","year":"2010","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0175","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1038\/nrneurol.2012.226","article-title":"Epigenetic changes in patients with multiple sclerosis","volume":"9","author":"Koch","year":"2013","journal-title":"Nat Rev Neurol"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0180","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/0920-9964(95)00023-2","article-title":"Further evidence for an association between schizophrenia and the HLA DQB1 gene locus","volume":"18","author":"Nimgaonkar","year":"1995","journal-title":"Schizophr Res"},{"issue":"5","key":"10.1016\/j.comppsych.2023.152370_bb0185","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1176\/ajp.156.5.771","article-title":"Schizophrenia and the HLA-DRB1 gene in the Japanese population","volume":"156","author":"Sasaki","year":"1999","journal-title":"Am J Psychiatry"},{"issue":"7","key":"10.1016\/j.comppsych.2023.152370_bb0190","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S0198-8859(01)00256-7","article-title":"Immune related genetic polymorphisms and schizophrenia among the Chinese","volume":"62","author":"Chowdari","year":"2001","journal-title":"Hum Immunol"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0195","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-5728(83)90058-9","article-title":"HLA-DR antigens in Mexican patients with Guillain-Barr\u00e9 syndrome","volume":"4","author":"Gorodezky","year":"1983","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.comppsych.2023.152370_bb0200","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1111\/j.1749-6632.1987.tb51310.x","article-title":"Immunogenetics of spontaneous, drug-induced, and experimental myasthenia gravis","volume":"505","author":"Dawkins","year":"1987","journal-title":"Ann N Y Acad Sci"},{"issue":"11","key":"10.1016\/j.comppsych.2023.152370_bb0205","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1212\/WNL.43.11.2426-a","article-title":"HLA and MS","volume":"43","author":"Hillert","year":"1993","journal-title":"Neurology."},{"issue":"6","key":"10.1016\/j.comppsych.2023.152370_bb0210","first-page":"1550","article-title":"Association of HLA-DQB1*0201 with stiff-man syndrome","volume":"77","author":"Pugliese","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"issue":"2 Suppl","key":"10.1016\/j.comppsych.2023.152370_bb0215","doi-asserted-by":"crossref","first-page":"S460","DOI":"10.1067\/mai.2003.108","article-title":"2. Cytokines and chemokines","volume":"111","author":"Borish","year":"2003","journal-title":"J Allergy Clin Immunol"},{"issue":"6","key":"10.1016\/j.comppsych.2023.152370_bb0220","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2165\/11633190-000000000-00000","article-title":"Antioxidants as antidepressants: fact or fiction","volume":"26","author":"Scapagnini","year":"2012","journal-title":"CNS Drugs"},{"issue":"Pt 7","key":"10.1016\/j.comppsych.2023.152370_bb0225","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1093\/brain\/awh191","article-title":"In vivo MRI of brain inflammation in human ischaemic stroke","volume":"127","author":"Saleh","year":"2004","journal-title":"Brain."},{"issue":"11","key":"10.1016\/j.comppsych.2023.152370_bb0230","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1038\/sj.mp.4002006","article-title":"The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression","volume":"12","author":"M\u00fcller","year":"2007","journal-title":"Mol Psychiatry"},{"issue":"10","key":"10.1016\/j.comppsych.2023.152370_bb0235","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1002\/jnr.21325","article-title":"Neuroinflammation and regulation of glial glutamate uptake in neurological disorders","volume":"85","author":"Tilleux","year":"2007","journal-title":"J Neurosci Res"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0240","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/npp.2011.205","article-title":"Psychoneuroimmunology meets neuropsychopharmacology: translational implications of the impact of inflammation on behavior","volume":"37","author":"Haroon","year":"2012","journal-title":"Neuropsychopharmacology."},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0245","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.neuropharm.2011.07.036","article-title":"Towards a glutamate hypothesis of depression: an emerging frontier of neuropsychopharmacology for mood disorders","volume":"62","author":"Sanacora","year":"2012","journal-title":"Neuropharmacology."},{"issue":"6","key":"10.1016\/j.comppsych.2023.152370_bb0250","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/schbul\/sbt141","article-title":"Inflammation and schizophrenia","volume":"39","author":"Kirkpatrick","year":"2013","journal-title":"Schizophr Bull"},{"issue":"2\u20133","key":"10.1016\/j.comppsych.2023.152370_bb0255","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1159\/000356536","article-title":"First-episode psychosis: an inflammatory state","volume":"21","author":"Zajkowska","year":"2014","journal-title":"Neuroimmunomodulation."},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0260","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1186\/s12974-020-01944-9","article-title":"Role of inflammasomes in multiple sclerosis and their potential as therapeutic targets","volume":"17","author":"Govindarajan","year":"2020","journal-title":"J Neuroinflammation"},{"issue":"6","key":"10.1016\/j.comppsych.2023.152370_bb0265","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amjms.2018.08.018","article-title":"The properties of cytokines in multiple sclerosis: pros and cons","volume":"356","author":"Wang","year":"2018","journal-title":"Am J Med Sci"},{"key":"10.1016\/j.comppsych.2023.152370_bb0270","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/758639","article-title":"Role of cytokines and toll-like receptors in the immunopathogenesis of Guillain-Barr\u00e9 syndrome","volume":"2014","author":"Nyati","year":"2014","journal-title":"Mediat Inflamm"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0275","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1038\/nrn2297","article-title":"From inflammation to sickness and depression: when the immune system subjugates the brain","volume":"9","author":"Dantzer","year":"2008","journal-title":"Nat Rev Neurosci"},{"issue":"3","key":"10.1016\/j.comppsych.2023.152370_bb0280","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00705-021-04959-6","article-title":"Viral infections and their relationship to neurological disorders","volume":"166","author":"Wouk","year":"2021","journal-title":"Arch Virol"},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0285","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2174\/156720206776875894","article-title":"Autoantibodies associated with psychiatric disorders","volume":"3","author":"Margutti","year":"2006","journal-title":"Curr Neurovasc Res"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0290","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1176\/jnp.23.1.jnp90","article-title":"The emerging link between autoimmune disorders and neuropsychiatric disease","volume":"23","author":"Kayser","year":"2011","journal-title":"J Neuropsychiatr Clin Neurosci"},{"issue":"12","key":"10.1016\/j.comppsych.2023.152370_bb0295","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.1017\/S003329171300295X","article-title":"Prevalence of anti-N-methyl-D-aspartate (NMDA) receptor [corrected] antibodies in patients with schizophrenia and related psychoses: a systematic review and meta-analysis","volume":"44","author":"Pollak","year":"2014","journal-title":"Psychol Med"},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0300","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1038\/mp.2011.154","article-title":"De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia","volume":"17","author":"Kirov","year":"2012","journal-title":"Mol Psychiatry"},{"issue":"3","key":"10.1016\/j.comppsych.2023.152370_bb0305","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1001\/2013.jamapsychiatry.86","article-title":"Increased prevalence of diverse N-methyl-D-aspartate glutamate receptor antibodies in patients with an initial diagnosis of schizophrenia: specific relevance of IgG NR1a antibodies for distinction from N-methyl-D-aspartate glutamate receptor encephalitis","volume":"70","author":"Steiner","year":"2013","journal-title":"JAMA Psychiat"},{"issue":"4","key":"10.1016\/j.comppsych.2023.152370_bb0310","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.biopsych.2013.07.018","article-title":"Antibodies to the N-methyl-D-aspartate receptor and other synaptic proteins in psychosis","volume":"75","author":"Deakin","year":"2014","journal-title":"Biol Psychiatry"},{"key":"10.1016\/j.comppsych.2023.152370_bb0315","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/j.physbeh.2014.04.038","article-title":"NMDA receptor hypofunction and the thalamus in schizophrenia","volume":"131","author":"Vukadinovic","year":"2014","journal-title":"Physiol Behav"},{"key":"10.1016\/j.comppsych.2023.152370_bb0320","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.schres.2019.05.027","article-title":"Thalamus-related anomalies as candidate mechanism-based biomarkers for psychosis","volume":"226","author":"Steullet","year":"2020","journal-title":"Schizophr Res"},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0325","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/j.autrev.2015.10.003","article-title":"A meta-analysis of serum and cerebrospinal fluid autoantibodies in neuropsychiatric systemic lupus erythematosus","volume":"15","author":"Ho","year":"2016","journal-title":"Autoimmun Rev"},{"issue":"2","key":"10.1016\/j.comppsych.2023.152370_bb0330","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1007\/s12016-021-08865-2","article-title":"Autoantibodies in neuropsychiatric systemic lupus erythematosus (NPSLE): can they be used as biomarkers for the differential diagnosis of this disease","volume":"63","author":"Manca","year":"2022","journal-title":"Clin Rev Allergy Immunol"},{"key":"10.1016\/j.comppsych.2023.152370_bb0335","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jaut.2017.07.007","article-title":"Modulation of inflammatory and immune responses by vitamin D","volume":"85","author":"Colotta","year":"2017","journal-title":"J Autoimmun"},{"issue":"9","key":"10.1016\/j.comppsych.2023.152370_bb0340","doi-asserted-by":"crossref","first-page":"8127","DOI":"10.3390\/nu7095383","article-title":"Regulation of dendritic cell function by vitamin D","volume":"7","author":"Barragan","year":"2015","journal-title":"Nutrients."},{"issue":"8","key":"10.1016\/j.comppsych.2023.152370_bb0345","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1177\/1352458509105579","article-title":"Explaining multiple sclerosis prevalence by ultraviolet exposure: a geospatial analysis","volume":"15","author":"Beretich","year":"2009","journal-title":"Mult Scler"},{"issue":"Pt 7","key":"10.1016\/j.comppsych.2023.152370_bb0350","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1093\/brain\/awq147","article-title":"Is hypovitaminosis D one of the environmental risk factors for multiple sclerosis","volume":"133","author":"Pierrot-Deseilligny","year":"2010","journal-title":"Brain."},{"issue":"16","key":"10.1016\/j.comppsych.2023.152370_bb0355","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1212\/WNL.0b013e318216715e","article-title":"Relationship of UV exposure to prevalence of multiple sclerosis in England","volume":"76","author":"Ramagopalan","year":"2011","journal-title":"Neurology."},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0360","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1017\/S0317167100011124","article-title":"A quantitative analysis of suspected environmental causes of MS","volume":"38","author":"Sloka","year":"2011","journal-title":"Can J Neurol Sci"},{"issue":"8","key":"10.1016\/j.comppsych.2023.152370_bb0365","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1177\/1352458513513968","article-title":"Sun exposure and multiple sclerosis risk in Norway and Italy: the EnvIMS study","volume":"20","author":"Bj\u00f8rnevik","year":"2014","journal-title":"Mult Scler"},{"issue":"1","key":"10.1016\/j.comppsych.2023.152370_bb0370","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1212\/WNL.0000000000002075","article-title":"Association between age at onset of multiple sclerosis and vitamin D level-related factors","volume":"86","author":"Laursen","year":"2016","journal-title":"Neurology."},{"issue":"5 Suppl","key":"10.1016\/j.comppsych.2023.152370_bb0375","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1177\/0269881112440512","article-title":"A critical review of major mortality risk factors for all-cause mortality in first-episode schizophrenia: clinical and research implications","volume":"26","author":"Beary","year":"2012","journal-title":"J Psychopharmacol"}],"container-title":["Comprehensive Psychiatry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X2300007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0010440X2300007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T20:36:31Z","timestamp":1762115791000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0010440X2300007X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,4]]},"references-count":75,"alternative-id":["S0010440X2300007X"],"URL":"https:\/\/doi.org\/10.1016\/j.comppsych.2023.152370","relation":{},"ISSN":["0010-440X"],"issn-type":[{"value":"0010-440X","type":"print"}],"subject":[],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between autoimmune diseases of the nervous system and schizophrenia: A systematic review and meta-analysis of cohort studies","name":"articletitle","label":"Article Title"},{"value":"Comprehensive Psychiatry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.comppsych.2023.152370","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"152370"}}